ArticleCancer immunology, immunotherapy : CII2026

Preclinical efficacy of iPSC-derived MUC1-targeted CAR-NK cells against esophageal squamous cell carcinoma.

Yuting Peng et al.PubMed ↗Publisher ↗

No numbers read from the abstract.